Cidara Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
| Presentation Information: | |
| Date: | |
| Time: | |
| Webcast: | A live audio webcast and replay of the presentation will be available in the Investors section on the Company’s website at www.cidara.com. |
About
Cidara is developing long-acting therapeutics to improve the standard of care for patients facing serious fungal or viral infections. The Company’s portfolio is comprised of breakthrough approaches aimed at transforming existing treatment and prevention paradigms, first with its lead antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) targeting influenza and other viral diseases from Cidara’s proprietary Cloudbreak® antiviral platform. Cidara is headquartered in
INVESTOR CONTACT:
(212) 915-2578
britchie@lifesciadvisors.com
MEDIA CONTACT:
Karen O’Shea, Ph.D.
(929) 469-3860
koshea@lifescicomms.com
Source: Cidara Therapeutics, Inc.
